ISBN-10:
1493980785
ISBN-13:
9781493980789
Pub. Date:
04/19/2018
Publisher:
Springer New York
Immunotherapy and Biomarkers in Neurodegenerative Disorders

Immunotherapy and Biomarkers in Neurodegenerative Disorders

by Martin Ingelsson, Lars Lannfelt
Current price is , Original price is $139.99. You

Temporarily Out of Stock Online

Please check back later for updated availability.

MARKETPLACE
1 New & Used Starting at $134.94

Overview

This practical volume examines a number of topics that explore the current status of immunotherapy and diagnostic markers for neurodegenerative disorders. With a focus on Alzheimer’s disease, the first sections of the book examine immunotherapeutic approaches for the aforementioned disease as well as for Parkinson’s disease and Huntington’s disease,
amongst others. The last section of the book covers the importance of biomarker techniques to catch these diseases early enough for the treatments to be most useful. Written for the Methods in
Pharmacology and Toxicology
series, this book contains the kind of detailed descriptions and implementation advice that will offer a smooth transition into the lab.


Authoritative and useful, Immunotherapy and Biomarkers in
Neurodegenerative Disorders
aims to aid in the continued progress in the development of novel immune-based drugs and diagnostic tools for these devastating brain diseases.

Product Details

ISBN-13: 9781493980789
Publisher: Springer New York
Publication date: 04/19/2018
Series: Methods in Pharmacology and Toxicology
Edition description: Softcover reprint of the original 1st ed. 2016
Pages: 289
Product dimensions: 7.01(w) x 10.00(h) x (d)

Table of Contents

Part I: Immunotherapy
Against Amyloid-b in
Alzheimer’s Disease



1. Immunotherapy Against Amyloid-β in Alzheimer’s Disease: An Overview


Niels D. Prins



2. Active Immunization Against the
Amyloid-β Peptide


Enchi Liu and J. Michael Ryan



3. Immunotherapy
Against N-Truncated Amyloid-β Oligomers


Thomas A.
Bayer and Oliver Wirths



4. Immunotherapy
Against Amyloid-β Protofibrils: Opportunities and Challenges


Lars
Lannfelt



Part II:
Immunotherapy in Other Neurodegenerative Disorders



5. Immunotherapy
Against α-Synuclein Pathology


Elvira
Valera and Eliezer Masliah



6. Extracellular α-Synuclein as a Target for
Immunotherapy


Jun Sung Lee and Seung-Jae Lee



7. Immunotherapy of Parkinson’s Disease


Achim Schneeberger,
Suzanne Hendrix, and Markus Mandler



8. Tau Immunotherapy


Einar M. Sigurdsson



9. Active and Passive Immunotherapy Against Tau: Effects and
Potential Mechanisms


Kiran Yanamandra, Marc
I. Diamond, and David M. Holtzman



10. Immunotherapy on Experimental Models for
Huntington’s Disease


Anne Messer



Part III: Biomarkers for Neurodegenerative Disorders



11. Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease


Henrik Zetterberg and
Jonathan M. Schott



12. Volumetric MRI as a Diagnostic Tool in
Alzheimer's Disease


Eric Westman, Lena Cavalin, and
Lars-Olof Wahlund



13. PET Imaging as a Diagnostic Tool in Alzheimer's
Disease


Juha O. Rinne



14. Αlpha-Synuclein as a Diagnostic
Biomarker for Parkinson’s Disease


Joakim Bergström and Martin Ingelsson



15. Imaging as a Diagnostic Tool in
Parkinson’s Disease


Johan Wikström and Torsten Danfors



16. Mass
Spectrometry-Based Proteomics in Biomarker Discovery for Neurodegenerative
Diseases


Sravani Musunuri,
Ganna Shevchenko, and Jonas Bergquist

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews